ICU Medical (ICUI) FY2012 results: revenue $317 million, up 4.9% on the year
ICU Medical Inc. (ICUI) reported revenue of $317 million for fiscal 2012, the year ended 31 December 2012, up 4.9% on the year before. Net income was $41 million, down 7.6%, and diluted earnings per share $2.80. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2013.
Revenue
$317 million
+4.9% on the year
FY2007FY2012
Operating margin
19.3%
21.6% a year earlier
FY2007FY2012
Net income
$41 million
-7.6% on the year
FY2007FY2012
Diluted EPS
$2.80
-11.1% on the year
FY2007FY2012
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Revenue
317
302
283
+4.9%
Cost of revenue
160
160
154
+0.3%
Gross profit
157
142
129
+9.9%
Gross margin
49.4%
47.1%
45.6%
Research and development
10.6
8.6
4.7
+23.8%
Selling, general and administrative
84.6
85.3
76.6
-0.8%
Operating income
61.3
65.2
47.7
-6.0%
Operating margin
19.3%
21.6%
16.8%
Pre-tax income
61.8
66.4
47.8
-6.9%
Income tax
20.6
21.8
17.9
-5.5%
Effective tax rate
33.2%
32.7%
37.4%
Net income
41.3
44.7
29.9
-7.6%
Net margin
13.0%
14.8%
10.6%
Diluted EPS
$2.80
$3.15
$2.23
-11.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Operating cash flow
66.3
64.5
33.1
+2.8%
Capital expenditure
19.2
15.8
23.2
+21.1%
Free cash flow
47.1
48.7
9.9
-3.2%
Free cash flow margin
14.9%
16.1%
3.5%
Cash from investing
-41.4
-45.7
19.6
Cash from financing
21.6
2.1
-22.9
+913.6%
Depreciation and amortisation
19.0
18.3
17.3
+3.9%
Share-based compensation
5.6
4.0
3.5
+38.5%
Buybacks
0.0
12.0
28.6
Diluted shares, weighted
15m
14m
14m
+4.0%
Shares outstanding at period end
14m
14m
14m
+4.2%
Balance sheet
$ million
FY2012
FY2011
FY2010
On the year
Last 8 years
Shareholders' equity
391
321
272
+21.9%
Debt
0.0
0.0
0.0
Other liabilities
37.7
40.5
37.9
-7.1%
Total liabilities and equity
429
361
310
+18.7%
Fixed assets
85.9
85.9
83.5
0.0%
Goodwill
1.5
1.5
1.5
0.0%
Intangible assets
10.0
11.4
14.8
-12.8%
Investments
79.3
60.4
14.5
+31.2%
Cash and equivalents
147
99.6
78.8
+47.5%
Receivables
49.1
43.6
50.9
+12.8%
Inventory
36.3
40.4
44.1
-10.1%
Other assets
19.5
18.3
21.5
+6.7%
Total assets
429
361
310
+18.7%
10-K for the year ended 31 December 2012, filed 26 February 2013: the filing.